A Multicenter, Open-Label Study To Investigate The Safety, Tolerability, And Pharmacokinetics Of Lacosamide (LCM) Oral Solution (Syrup) As Adjunctive Therapy In Children With Partial-Onset Seizures.

Trial Profile

A Multicenter, Open-Label Study To Investigate The Safety, Tolerability, And Pharmacokinetics Of Lacosamide (LCM) Oral Solution (Syrup) As Adjunctive Therapy In Children With Partial-Onset Seizures.

Completed
Phase of Trial: Phase II

Latest Information Update: 20 Jul 2018

At a glance

  • Drugs Lacosamide (Primary)
  • Indications Partial epilepsies
  • Focus Adverse reactions
  • Sponsors UCB
  • Most Recent Events

    • 05 Dec 2017 Interim pooled analysis results (cut-off date: 01 Nov 2016) from three open-label trials (NCT00938431,NCT00938912 and NCT01964560) presented at the 71st Annual Meeting of the American Epilepsy Society
    • 14 Dec 2015 Study design changed from Randomized to non- randomized as reported by ClinicalTrials.gov.
    • 27 Aug 2014 New source identified and integrated (European Clinical Trials Database - EudraCT2011-001558-27)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top